Literature DB >> 18417591

Human parainfluenza virus type 2 V protein inhibits genome replication by binding to the L protein: possible role in promoting viral fitness.

Machiko Nishio1, Junpei Ohtsuka, Masato Tsurudome, Tetsuya Nosaka, Daniel Kolakofsky.   

Abstract

The human parainfluenza virus type 2 (hPIV2) V protein plays important roles in inhibiting the host interferon response and promoting virus growth, but its role in hPIV2 replication and transcription is not clear. A green fluorescent protein (GFP)-expressing a negative-sense minigenomic construct of hPIV2 has been established by standard technology, with helper plasmids expressing the nucleocapsid protein (NP), phosphoprotein (P), and large RNA polymerase (L) protein, to examine the role of V protein. We found that the simultaneous expression of wild-type V protein in the minigenome system inhibited GFP expression, at least in part, by inhibiting minigenome replication. In contrast, expression of C terminally truncated or mutant hPIV2 V proteins had no effect. Moreover, the V protein of simian virus 41, the rubulavirus most closely related virus to hPIV2, also inhibited GFP expression, whereas that of PIV5, a more distantly related rubulavirus, did not. Using these other rubulavirus V proteins, as well as various mutant hPIV2 V proteins, we found that the ability of V protein to inhibit GFP expression correlated with its ability to bind to L protein via its C-terminal V protein-specific region, but there was no correlation with NP binding. A possible role for this inhibition of genome replication in promoting viral fitness is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18417591      PMCID: PMC2447057          DOI: 10.1128/JVI.02635-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions.

Authors:  R G Paterson; G P Leser; M A Shaughnessy; R A Lamb
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

2.  All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation.

Authors:  Dominique Garcin; Jean-Baptiste Marq; Laura Strahle; Philippe le Mercier; Daniel Kolakofsky
Journal:  Virology       Date:  2002-04-10       Impact factor: 3.616

3.  Sendai virus C protein physically associates with Stat1.

Authors:  K Takeuchi; T Komatsu; J Yokoo; A Kato; T Shioda; Y Nagai; B Gotoh
Journal:  Genes Cells       Date:  2001-06       Impact factor: 1.891

4.  Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state.

Authors:  D Garcin; P Latorre; D Kolakofsky
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons.

Authors:  M Nishio; M Tsurudome; M Ito; M Kawano; H Komada; Y Ito
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter.

Authors:  J Andrejeva; K S Childs; D F Young; T S Carlos; N Stock; S Goodbourn; R E Randall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

7.  Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis.

Authors:  L Didcock; D F Young; S Goodbourn; R E Randall
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Mapping of domains on the human parainfluenza virus type 2 nucleocapsid protein (NP) required for NP-phosphoprotein or NP-NP interaction.

Authors:  Machiko Nishio; Masato Tsurudome; Morihiro Ito; Mitsuo Kawano; Shigeru Kusagawa; Hiroshi Komada; Yasuhiko Ito
Journal:  J Gen Virol       Date:  1999-08       Impact factor: 3.891

9.  Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses.

Authors:  B Gotoh; K Takeuchi; T Komatsu; J Yokoo; Y Kimura; A Kurotani; A Kato; Y Nagai
Journal:  FEBS Lett       Date:  1999-10-08       Impact factor: 4.124

10.  Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter.

Authors:  U J Buchholz; S Finke; K K Conzelmann
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  13 in total

1.  Identification of human parainfluenza virus type 2 (HPIV-2) V protein amino acid residues that reduce binding of V to MDA5 and attenuate HPIV-2 replication in nonhuman primates.

Authors:  Anne Schaap-Nutt; Caraline Higgins; Emerito Amaro-Carambot; Sheila M Nolan; Christopher D'Angelo; Brian R Murphy; Peter L Collins; Alexander C Schmidt
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

Review 2.  The regulation of type I interferon production by paramyxoviruses.

Authors:  Stephen Goodbourn; Richard E Randall
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

Review 3.  Initiation and regulation of paramyxovirus transcription and replication.

Authors:  Sarah L Noton; Rachel Fearns
Journal:  Virology       Date:  2015-02-13       Impact factor: 3.616

Review 4.  Pathogenesis of acute respiratory illness caused by human parainfluenza viruses.

Authors:  Henrick Schomacker; Anne Schaap-Nutt; Peter L Collins; Alexander C Schmidt
Journal:  Curr Opin Virol       Date:  2012-03-03       Impact factor: 7.090

5.  Regulation of Viral RNA Synthesis by the V Protein of Parainfluenza Virus 5.

Authors:  Yang Yang; James Zengel; Minghao Sun; Katrina Sleeman; Khalid Amine Timani; Jason Aligo; Paul Rota; Jianguo Wu; Biao He
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

6.  A Point Mutation in the RNA-Binding Domain of Human Parainfluenza Virus Type 2 Nucleoprotein Elicits Abnormally Enhanced Polymerase Activity.

Authors:  Yusuke Matsumoto; Keisuke Ohta; Daniel Kolakofsky; Machiko Nishio
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

7.  Human parainfluenza virus type 2 L protein regions required for interaction with other viral proteins and mRNA capping.

Authors:  Machiko Nishio; Masato Tsurudome; Dominique Garcin; Hiroshi Komada; Morihiro Ito; Philippe Le Mercier; Tetsuya Nosaka; Daniel Kolakofsky
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

8.  Human parainfluenza virus type 2 polymerase complex recognizes leader promoters of other species belonging to the genus Rubulavirus.

Authors:  Yusuke Matsumoto; Keisuke Ohta; Machiko Nishio
Journal:  Med Microbiol Immunol       Date:  2017-09-07       Impact factor: 3.402

9.  Graf1 Controls the Growth of Human Parainfluenza Virus Type 2 through Inactivation of RhoA Signaling.

Authors:  Keisuke Ohta; Hideo Goto; Yusuke Matsumoto; Natsuko Yumine; Masato Tsurudome; Machiko Nishio
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

10.  Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates.

Authors:  Anne Schaap-Nutt; Christopher D'Angelo; Margaret A Scull; Emerito Amaro-Carambot; Machiko Nishio; Raymond J Pickles; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  Virology       Date:  2009-12-07       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.